Assignee
OCULAR THERAPEUTIX INC
US·18 granted patents·24 pending applications·36 citations·filing 2016–2025
Top patents by PatentIndex Score
42 records- 0196US11331267B2Sustained release biodegradable intracanalicular inserts comprising a hydrogel and cyclosporineOCULAR THERAPEUTIX INC·Filed 2021·Granted May 17, 2022·5 cites·23 claims
- 0296US11291627B1Sustained release biodegradable intracanalicular inserts comprising a hydrogel and cyclosporineOCULAR THERAPEUTIX INC·Filed 2021·Granted Apr 5, 2022·6 cites·23 claims
- 0395US11534396B2Methods of treatment with an ocular implant containing a tyrosine kinase inhibitorOCULAR THERAPEUTIX INC·Filed 2022·Granted Dec 27, 2022·9 cites·29 claims
- 0494US12161753B2Sustained release biodegradable intracanalicular inserts comprising a hydrogel and an active agentOCULAR THERAPEUTIX INC·Filed 2021·Granted Dec 10, 2024·2 cites·26 claims
- 0594US11439592B2Ocular implant containing a tyrosine kinase inhibitorOCULAR THERAPEUTIX INC·Filed 2021·Granted Sep 13, 2022·6 cites·27 claims
- 0693US11622935B2Methods of treating ocular diseases using polyalkylene glycol intracameral implants with polyactide travoprost particlesOCULAR THERAPEUTIX INC·Filed 2022·Granted Apr 11, 2023·2 cites·2 claims
- 0792US11779536B2Sustained release biodegradable intracanalicular inserts comprising a hydrogel and cyclosporineOCULAR THERAPEUTIX INC·Filed 2022·Granted Oct 10, 2023·1 cites·20 claims
- 0890US12357565B2Ocular implant containing a tyrosine kinase inhibitorOCULAR THERAPEUTIX INC·Filed 2022·Granted Jul 15, 2025·1 cites·10 claims
- 0990US11559429B1Punctal plug and bioadhesivesOCULAR THERAPEUTIX INC·Filed 2022·Granted Jan 24, 2023·1 cites·1 claims
- 1087US12023276B2Intracanalicular depot inserter deviceOCULAR THERAPEUTIX INC·Filed 2022·Granted Jul 2, 2024·1 cites·12 claims
- 1187US2026053735A1Ocular hydrogel tyrosine kinase inhibitor implantsOCULAR THERAPEUTIX INC·Filed 2025·Application pending·0 cites
- 1285US2025057759A1Sustained release biodegradable intracanalicular inserts comprising a hydrogel and cyclosporineOCULAR THERAPEUTIX INC·Filed 2024·Application pending·0 cites
- 1384US12310890B2Punctal plug and bioadhesivesOCULAR THERAPEUTIX INC·Filed 2023·Granted May 27, 2025·0 cites·2 claims
- 1484US12109302B2Sustained release biodegradable intracanalicular inserts comprising a hydrogel and cyclosporineOCULAR THERAPEUTIX INC·Filed 2023·Granted Oct 8, 2024·0 cites·20 claims
- 1581US12329853B2Compositions and methods for treating ocular diseasesOCULAR THERAPEUTIX INC·Filed 2022·Granted Jun 17, 2025·0 cites·20 claims
- 1681US11458041B2Punctal plug and bioadhesivesOCULAR THERAPEUTIX INC·Filed 2016·Granted Oct 4, 2022·2 cites·1 claims
- 1781US2025268750A1Punctal plug and bioadhesivesOCULAR THERAPEUTIX INC·Filed 2025·Application pending·0 cites
- 1880US12150896B2Punctal plug and bioadhesivesOCULAR THERAPEUTIX INC·Filed 2022·Granted Nov 26, 2024·0 cites·2 claims
- 1980US2024285518A1Ocular hydrogel tyrosine kinase inhibitor implantsOCULAR THERAPEUTIX INC·Filed 2024·Application pending·0 cites
- 2078US2025268818A1Compositions and methods for treating ocular diseasesOCULAR THERAPEUTIX INC·Filed 2025·Application pending·0 cites
- 2177US2025120906A1Sustained release biodegradable intracanalicular inserts comprising a hydrogel and an active agentOCULAR THERAPEUTIX INC·Filed 2024·Application pending·0 cites
- 2277US2025108003A1Methods of treating allergic conjunctivitisOCULAR THERAPEUTIX INC·Filed 2024·Application pending·0 cites
- 2375US2023040637A1Ocular hydrogel tyrosine kinase inhibitor implantsOCULAR THERAPEUTIX INC·Filed 2022·Application pending·0 cites
- 2474US2025332094A1Ocular implant containing a tyrosine kinase inhibitorOCULAR THERAPEUTIX INC·Filed 2025·Application pending·0 cites
- 2573US2024165018A1Hydrogel implants for lowering intraocular pressureOCULAR THERAPEUTIX INC·Filed 2023·Application pending·0 cites
- 2672US12144889B2Methods of treating allergic conjunctivitisOCULAR THERAPEUTIX INC·Filed 2022·Granted Nov 19, 2024·0 cites·8 claims
- 2770US2024390183A1Intracanalicular depot inserter deviceOCULAR THERAPEUTIX INC·Filed 2024·Application pending·0 cites
- 2870US2023285282A1Ocular implant containing an active ingredientOCULAR THERAPEUTIX INC·Filed 2023·Application pending·0 cites
- 2969US2021251893A1Compositions and Methods for Treating Ocular DiseasesOCULAR THERAPEUTIX INC·Filed 2021·Application pending·0 cites
- 3066US12226341B2Implant injector deviceOCULAR THERAPEUTIX INC·Filed 2022·Granted Feb 18, 2025·0 cites·29 claims
- 3165US2020337989A1Ocular hydrogel tyrosine kinase inhibitor implantsOCULAR THERAPEUTIX INC·Filed 2020·Application pending·0 cites
- 3265US2026048008A1Organogels for sustained drug delivery, methods of preparation and use thereofOCULAR THERAPEUTIX INC·Filed 2023·Application pending·0 cites
- 3364US12453724B2Ocular implant containing a tyrosine kinase inhibitorOCULAR THERAPEUTIX INC·Filed 2025·Granted Oct 28, 2025·0 cites·12 claims
- 3464US2023390189A1Ocular implant containing an active ingredientOCULAR THERAPEUTIX INC·Filed 2021·Application pending·0 cites
- 3562US2025114373A1Intracanalicular insert comprising an antimicrobial agentOCULAR THERAPEUTIX INC·Filed 2023·Application pending·0 cites
- 3662US2025092013A1Prodrugs of axitinibOCULAR THERAPEUTIX INC·Filed 2022·Application pending·0 cites
- 3761US2025064760A1Intracanalicular insert comprising a non-steroidal anti-inflammatory agentOCULAR THERAPEUTIX INC·Filed 2023·Application pending·0 cites
- 3860US2025221848A1Implant injector deviceOCULAR THERAPEUTIX INC·Filed 2025·Application pending·0 cites
- 3959US2024042713A1Extruded ocular inserts or implants and methods thereofOCULAR THERAPEUTIX INC·Filed 2022·Application pending·0 cites
- 4056US2020337990A1Hydrogel implants for lowering intraocular pressureOCULAR THERAPEUTIX INC·Filed 2020·Application pending·0 cites
- 4155US2022183969A1Ocular insert containing a glucocorticoidOCULAR THERAPEUTIX INC·Filed 2021·Application pending·0 cites
- 4249US2020337993A1Intracanalicular hydrogel inserts for the delivery of anestheticsOCULAR THERAPEUTIX INC·Filed 2020·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →